Gold Takes the Throne as Safe Haven AgainThe recent escalation in the Middle East — particularly Israel’s surprise strike on Iran — has stirred up significant volatility in global financial markets. Oil prices surged, stock markets around the world turned red, just as many had predicted. However, in a surprising twist, capital did not rush into the usual safe havens like the US dollar or Treasury bonds. Instead, it flowed decisively into gold.
In fact, US Treasury yields have soared from 3.98% in April to around 4.42% now. This surge doesn’t signal growing confidence — it reflects investor demand for higher returns to compensate for the rising risk of holding dollar-denominated assets.
Against this backdrop, gold is emerging as an “unshackled safe haven” — immune to political instability tied to fiat-currency-issuing nations. The precious metal is once again proving its value in times of global uncertainty.
Buy!!
Why Recursion Pharmaceuticals RXRX Could Be the NVDA of BiotechRecursion Pharmaceuticals RXRX is rapidly emerging as a transformative force in drug discovery, leveraging cutting-edge artificial intelligence and automation to industrialize and accelerate the development of new medicines. Here’s why RXRX could be the next NVIDIA (NVDA) of biotechnology and why its stock could soar by year-end:
1. AI-Powered Drug Discovery Platform with Unmatched Scale
Recursion integrates AI, machine learning, automation, and advanced data science to decode biology and chemistry, dramatically reducing the time and cost of drug discovery.
The company’s proprietary BioHive-2 supercomputer, built with NVIDIA’s DGX H100 systems, is the most powerful AI computing system wholly owned by any biopharma company, enabling Recursion to process biological data at unprecedented speeds.
By reducing the number of compounds needed for clinical candidates from thousands to just 136–200 and shrinking development timelines to under a year, RXRX is fundamentally changing the economics of pharmaceutical R&D.
2. Strategic Partnerships and Industry Validation
RXRX has forged high-profile partnerships with pharmaceutical giants such as Bayer, Roche/Genentech, Takeda, and Sanofi, validating its platform and unlocking milestone payments that could exceed $20 billion over time.
The company’s collaboration with AI biotech Exscientia in a $700 million deal further cements its leadership in the AI-driven drug discovery space, creating a pipeline of 10 clinical and preclinical programs with hundreds of millions in potential milestones.
NVIDIA itself holds over 7.7 million shares of RXRX, making it one of NVIDIA’s largest biotech investments and a strong endorsement of Recursion’s technology and long-term vision.
3. Explosive Revenue Growth and Strong Cash Position
Analysts forecast Recursion’s revenue to grow at a 65% CAGR from $58.8 million in 2024 to $263 million by 2027, far outpacing the broader biotech sector.
The company ended 2024 with over $600 million in cash, providing a solid runway for continued investment in R&D, platform expansion, and clinical trials.
Wall Street analysts expect more than 50% upside in RXRX stock over the next 12–24 months, with multiple clinical milestones and partnership announcements as near-term catalysts.
4. Disruptive Vision: The “Virtual Cell” and Beyond
RXRX is building toward a “virtual cell,” where AI models can simulate biological processes with such accuracy that wet lab experiments shift from data generation to validating computational predictions.
This approach could dramatically improve drug development success rates, addressing the industry’s notorious 95% failure rate and positioning Recursion as the go-to platform for next-generation drug discovery.
5. Market Sentiment and Institutional Support
RXRX has caught the attention of growth investors and major funds, including Cathie Wood’s ARK Invest, further boosting its profile and liquidity.
Recent stock surges and high trading volumes reflect growing investor confidence in Recursion’s disruptive potential and the broader AI-in-biotech trend.
Gold Soars – Heading Towards 3,500 USD/ounce?Gold prices closed yesterday at 3,457.7 USD/ounce, up 0.12% from the previous day, fluctuating between 3,453.7 USD and 3,458.1 USD/ounce, marking the highest level in the past two months.
XAU/USD is currently maintaining an uptrend within a well-defined price channel, with strong support at the 3,390–3,400 range. After a short correction, the price could continue to rise if it holds above the EMA34, with the next target towards the 3,445–3,460 range and further up to 3,500 USD/ounce.
This upward momentum is supported by geopolitical tensions in the Middle East, particularly between Israel and Iran, driving demand for gold as a safe-haven asset. U.S. CPI data lower than expected has also increased expectations of a Fed rate cut, alongside central banks increasing gold reserves, all contributing to the continued rise in gold prices.
EURUSD: Awaiting Confirmation to Continue the UptrendThe EUR/USD pair closed yesterday at 1.1550, moving within the 1.1526–1.1558 range. The euro continues its bullish trend, driven by U.S. inflation data coming in lower than expected, which increases expectations of an upcoming rate cut by the Fed. In addition, geopolitical tensions in the Middle East—particularly between Israel and Iran—have slightly weakened the U.S. dollar, providing additional support to the euro.
From a technical perspective, the price is currently correcting toward the 1.1480 area, where the ascending trendline converges with the exponential moving average. This is a key support zone. If it holds and a clear bullish signal emerges, EURUSD could rebound and move toward the 1.1610 resistance level.
Main scenario: look for buying opportunities around 1.1480 if a bullish confirmation appears, targeting 1.1610.
Alternative scenario: if the 1.1480 level is broken, the short-term uptrend could be at risk.
PTON Peloton Potential Buyout Interest from Amazon or NikeIf you haven`t bought the dip on PTON, before the rally:
Now Peloton Interactive PTON remains a compelling bullish candidate in 2025, supported not only by strategic buyout interest from major players like Amazon and Nike but also by significant unusual options activity signaling strong investor conviction in a near-term upside move. These factors combined create a powerful catalyst for a potential stock rally.
1. Confirmed Buyout Interest from Amazon and Nike
Since 2022, credible reports have indicated that Amazon and Nike are exploring acquisition opportunities for Peloton, recognizing its value as a leading connected fitness platform with over 2 million subscribers.
Amazon’s interest fits its broader health and smart home ambitions, while Nike sees Peloton as a strategic extension of its digital fitness ecosystem.
Such buyout interest implies a potential premium valuation, which could trigger a sharp upward re-rating of Peloton’s shares if a deal materializes or even if speculation intensifies.
2. Massive Unusual Call Option Activity for July 18, 2025 Expiry
A mystery trader recently purchased over 80,000 call options on Peloton with a $7 strike price expiring July 18, 2025, representing a $3.1 million bet on a price rise within the next few months.
On May 20, 2025, over 90,000 contracts of the $7 strike call expiring July 18, 2025 traded, equating to roughly 9 million underlying shares—well above Peloton’s average daily volume.
This unusually high call volume signals strong bullish sentiment and possible insider or institutional anticipation of a positive event, such as a buyout announcement or operational turnaround.
3. Strategic Fit and Synergies for Acquirers
Peloton’s subscription-based connected fitness platform offers Amazon and Nike a valuable recurring revenue stream and engaged user base.
Amazon could integrate Peloton’s offerings into its ecosystem of devices, health services, and e-commerce, while Nike could leverage Peloton’s content and hardware to deepen its digital fitness presence.
The potential for cross-selling, brand synergy, and data monetization enhances Peloton’s attractiveness as an acquisition target.
4. Attractive Valuation and Growth Potential
Peloton’s market cap has contracted significantly, making it an affordable target for large corporations with strategic interests in health and fitness.
Recent product launches, cost-cutting measures, and renewed marketing efforts aim to stabilize and grow Peloton’s subscriber base and revenue.
The connected fitness market continues to expand, driven by consumer demand for at-home and hybrid workout solutions.
5. Technical and Sentiment Indicators
The stock has shown signs of stabilizing after recent volatility, with support forming near $6–$6.50.
The surge in call options activity, especially at strikes above current prices, suggests growing investor confidence in a near-term breakout.
Historical patterns show Peloton’s stock reacts strongly to buyout rumors and unusual options volume, often resulting in rapid price appreciation.
Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
Toward $3,500? Gold Faces Key Policy DecisionsGold is currently trading around $3,438 and continues to show positive momentum. After a week focused on inflation data, the gold market is now shifting its attention to interest rate decisions and policy guidance from major central banks.
The week begins with the Empire State Manufacturing Index, a key indicator of economic activity in the New York region. Following that, the Bank of Japan (BoJ) will announce its monetary policy decision, and investors are closely watching to see whether the BoJ will continue normalizing its interest rates.
Next comes U.S. retail sales data for May — a crucial gauge of consumer spending, which remains the backbone of the U.S. economy. Any signs of weakness in consumer activity could increase expectations for Federal Reserve rate cuts.
However, the main focus remains the upcoming Fed meeting. While markets widely expect rates to be held steady, investors are awaiting clear signals from Chair Jerome Powell regarding the path and timing of potential rate cuts ahead.
According to Kitco’s weekly gold survey, professional analysts remain optimistic about gold’s outlook, while retail investors are showing more caution.
With central bank decisions approaching and geopolitical tensions lingering, investors need to stay alert. Risks such as rising social unrest in the U.S., escalating conflicts in the Middle East, and ongoing de-dollarization trends are all fueling demand for gold as a safe-haven asset.
Given expectations that the Fed will hold rates steady, gold maintains its defensive appeal. In my view, the precious metal may soon retest its highs near $3,500, as its role as a global safe haven becomes even more pronounced amid mounting uncertainty.
Gold rallies amid global unrestGold continues to assert its strong position as it surged further last week, reaching $3,440 per ounce by the weekend. This upward momentum has been driven by two key factors: escalating geopolitical tensions in the Middle East and growing expectations that the US Federal Reserve may soon begin cutting interest rates.
Many experts believe the bullish trend is likely to extend into this week, with the next psychological target set at $3,500. That said, a brief pullback cannot be ruled out after such a rapid ascent.
From my perspective, following the recent period of consolidation, gold appears to be regaining strength for another attempt at new highs. The ongoing global political uncertainty continues to fuel demand for this safe-haven asset.
As gold pushes higher, investors should ride the trend—but with caution. Staying closely informed on Fed policy shifts and geopolitical developments will be essential for making well-timed, rational trading decisions in this sensitive market environment.
USDCAD Is Going Up! Buy!
Please, check our technical outlook for USDCAD.
Time Frame: 2h
Current Trend: Bullish
Sentiment: Oversold (based on 7-period RSI)
Forecast: Bullish
The market is approaching a key horizontal level 1.356.
Considering the today's price action, probabilities will be high to see a movement to 1.360.
P.S
We determine oversold/overbought condition with RSI indicator.
When it drops below 30 - the market is considered to be oversold.
When it bounces above 70 - the market is considered to be overbought.
Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
Like and subscribe and comment my ideas if you enjoy them!
Gold becomes a strategic anchorPrecious metals continue to climb as investors rush into safe-haven assets following Israel’s airstrikes on Iran, sparking fears of a broader conflict in the Middle East. Many now view the confrontation between Israel and Iran as the most significant geopolitical event since the Russia–Ukraine war. In times of economic turbulence and geopolitical uncertainty, gold once again stands out as a reliable store of value.
Adding to the bullish case, weaker-than-expected U.S. inflation data earlier this week has strengthened expectations of a potential rate cut by the Federal Reserve. This shift has put downward pressure on the dollar and Treasury yields, giving gold even more room to rise.
From my perspective, when geopolitics and monetary policy both signal instability, gold is no longer just a defensive hedge — it becomes a proactive strategy. Holding gold right now is not just about safety — it’s about positioning for a new phase where capital seeks true value and trusted refuge.
USD/JPY(20250616)Today's AnalysisMarket news:
Trump: The United States may still intervene in the Iran-Israel conflict. If Iran launches an attack on the United States, the United States will "fight back with all its strength on an unprecedented scale." Iran and Israel should reach an agreement.
Technical analysis:
Today's buying and selling boundaries:
143.79
Support and resistance levels:
145.47
144.84
144.43
143.15
142.74
142.12
Trading strategy:
If the price breaks through 144.43, consider buying in, the first target price is 144.84
If the price breaks through 143.79, consider selling in, the first target price is 143.15
USOIL Will Move Higher! Buy!
Please, check our technical outlook for USOIL.
Time Frame: 1D
Current Trend: Bullish
Sentiment: Oversold (based on 7-period RSI)
Forecast: Bullish
The price is testing a key support 71.393.
Current market trend & oversold RSI makes me think that buyers will push the price. I will anticipate a bullish movement at least to 78.089 level.
P.S
Overbought describes a period of time where there has been a significant and consistent upward move in price over a period of time without much pullback.
Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
Like and subscribe and comment my ideas if you enjoy them!
EURJPY Will Go Higher From Support! Buy!
Please, check our technical outlook for EURJPY.
Time Frame: 6h
Current Trend: Bullish
Sentiment: Oversold (based on 7-period RSI)
Forecast: Bullish
The price is testing a key support 164.890.
Current market trend & oversold RSI makes me think that buyers will push the price. I will anticipate a bullish movement at least to 166.192 level.
P.S
Overbought describes a period of time where there has been a significant and consistent upward move in price over a period of time without much pullback.
Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
Like and subscribe and comment my ideas if you enjoy them!
GOLD Is Very Bullish! Buy!
Please, check our technical outlook for GOLD.
Time Frame: 9h
Current Trend: Bullish
Sentiment: Oversold (based on 7-period RSI)
Forecast: Bullish
The market is approaching a key horizontal level 3,327.72.
Considering the today's price action, probabilities will be high to see a movement to 3,385.41.
P.S
Please, note that an oversold/overbought condition can last for a long time, and therefore being oversold/overbought doesn't mean a price rally will come soon, or at all.
Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
Like and subscribe and comment my ideas if you enjoy them!
AUD/USD BULLISH BIAS RIGHT NOW| LONG
Hello, Friends!
AUD/USD pair is in the downtrend because previous week’s candle is red, while the price is clearly falling on the 15m timeframe. And after the retest of the support line below I believe we will see a move up towards the target above at 0.651 because the pair oversold due to its proximity to the lower BB band and a bullish correction is likely.
Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
✅LIKE AND COMMENT MY IDEAS✅
WOOF Petco Health & Wellness Company Potential Bullish ReversalIf you haven`t sold WOOF before this major retracement:
WOOF Petco Health and Wellness Company has experienced a notable selloff recently, with its stock price declining to around $2.47 as of mid-June 2025. However, several fundamental and technical factors suggest that WOOF could be poised for a meaningful reversal and upside recovery in the near to medium term.
1. Attractive Valuation and Upside Potential
Despite the recent pullback, Petco’s stock is trading at a compelling valuation relative to its long-term growth potential.
Price forecasts for 2025 indicate an average target of approximately $3.55, representing a 43.7% upside from current levels.
More optimistic scenarios project highs up to $7.05 within this year, suggesting significant room for a rebound if market sentiment improves.
Long-term forecasts are even more bullish, with price targets of $14 by 2030 and as high as $77 by 2040, reflecting confidence in Petco’s strong market position and growth prospects.
2. Resilient Business Model in a Growing Pet Care Market
Petco operates in the resilient pet care and wellness industry, which benefits from secular trends such as increased pet ownership, premiumization of pet products, and growing consumer spending on pet health.
The company’s omni-channel approach—combining e-commerce with physical stores and veterinary services—positions it well to capture multiple revenue streams.
Petco’s focus on health and wellness services, including veterinary care and pet insurance, provides higher-margin growth opportunities that can drive profitability improvements.
3. Technical Signs of Stabilization and Potential Reversal
After the recent selloff, WOOF’s stock price has found some support near the $2.40–$2.50 level, with increased trading volumes indicating growing investor interest.
The stock’s recent modest gains and stabilization suggest that selling pressure may be easing, setting the stage for a potential technical rebound.
Options market activity and analyst upgrades reflect improving sentiment.
4. Improving Operational Execution and Financial Health
Petco has been investing in expanding its veterinary services and digital capabilities, which are expected to contribute to revenue growth and margin expansion.
The company’s recent earnings calls and financial reports highlight progress in cost management and customer engagement initiatives.
Strong cash flow generation and manageable debt levels provide flexibility to invest in growth and weather macroeconomic uncertainties.
5. Market Sentiment and Analyst Support
While some analysts remain cautious, the overall sentiment is shifting toward a more constructive outlook, with several price target upgrades and “hold” to “buy” rating adjustments.
The combination of attractive valuation, improving fundamentals, and sector tailwinds is likely to attract renewed institutional interest.
Bullish Thesis: Why Oscar Health OSCR Could Rally Strong in 2025Oscar Health, OSCR, a technology-driven health insurance company, is positioned for a significant stock price appreciation in 2025. Despite some mixed short-term sentiment, the long-term outlook and recent analyst forecasts suggest a potential rally that could more than double the current share price. Here’s why OSCR could be a compelling bullish opportunity this year:
1. Strong Analyst Price Targets Indicate Upside of Over 125%
According to recent forecasts, OSCR is expected to reach an average price of $31.40 in 2025, with some analysts projecting highs as much as $41.31—a potential upside exceeding 125% from the current price near $13.95.
Monthly forecasts show a steady upward trajectory, with July 2025 targets around $37.24 and December 2025 targets near $34.67, highlighting sustained bullish momentum throughout the year.
The average 12-month price target is around $34.40, representing a 146% upside, signaling strong confidence in OSCR’s growth prospects.
2. Innovative Business Model and Growth Potential
Oscar Health leverages technology and data analytics to offer user-friendly, transparent health insurance plans, differentiating itself in a traditionally complex industry.
Its focus on member engagement, telemedicine, and cost-effective care management positions it well to capture market share as healthcare consumers increasingly demand digital-first solutions.
The company’s expanding footprint in both individual and Medicare Advantage markets provides multiple growth avenues.
3. Long-Term Vision and Market Opportunity
Beyond 2025, forecasts remain highly bullish, with OSCR projected to reach $53.77 by 2027 and nearly $100 by 2030, reflecting strong secular growth potential in the health insurance and digital health sectors.
Analysts see Oscar as a disruptive force with the potential to reshape healthcare delivery, driving substantial long-term shareholder value.
4. Improving Financial Metrics and Operational Execution
Oscar has been improving its loss ratios and operating efficiencies, which are critical for sustainable profitability.
The company’s investments in technology infrastructure and data-driven care management are expected to translate into better margins and revenue growth over time.
5. Market Sentiment and Analyst Ratings
While some platforms show mixed short-term sentiment, the dominant analyst consensus is a "Buy" or "Moderate Buy," supported by strong price targets and growth forecasts.
The stock’s current undervaluation relative to its growth potential creates a favorable risk-reward profile for investors.
SNAP Upside PotentialIf you haven`t bought SNAP before the previous earnings:
SNAP Key Fundamental Strengths in Q1 2025:
Metric Q1 2025 Result Year-over-Year Change
Revenue $1.36 billion +14%
Daily Active Users (DAU) 460 million +9%
Monthly Active Users (MAU) 900 million+
Net Loss $140 million -54% (improved)
Adjusted EBITDA $108 million +137%
Operating Cash Flow $152 million +72%
Free Cash Flow $114 million +202%
SNAP strong fundamental performance in Q1 2025, marked by accelerating revenue growth, expanding user engagement, sharply improving profitability, and robust cash flow generation, sets a solid foundation for a potential stock rally this year.
The company’s innovation in AR, diversified revenue streams, and healthy balance sheet further support a bullish outlook. Investors focusing on fundamentals can view Snap as a growth stock with improving financial health and significant upside potential in 2025.
My price target is $14.
Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
US30 BULLISH BIAS RIGHT NOW| LONG
US30 SIGNAL
Trade Direction: short
Entry Level: 42,200.7
Target Level: 42,556.5
Stop Loss: 41,963.5
RISK PROFILE
Risk level: medium
Suggested risk: 1%
Timeframe: 6h
Disclosure: I am part of Trade Nation's Influencer program and receive a monthly fee for using their TradingView charts in my analysis.
✅LIKE AND COMMENT MY IDEAS✅